CFO Tobin Schilke sold $585K of Revance Therapeutics, Inc.

Sold$584,884

$31.59Price

18,517Shares

−20%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Mar 9. Filed Thu, Mar 9, 4:46 PM ET, after the close. Not investment advice.